Is Genomma Lab Internacional stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Genomma Lab Internacional pays dividends. Last time was Tuesday 17th of September 2024 where the investors holding the stock on Friday 13th of September 2024 were paid $0.2 per share. Over the last 11 times between 2021 and 2024, Genomma Lab Internacional has paid $3.2888 with an average of $0.3 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Genomma Lab Internacional 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $1.080, you would have made a profit of $0.190 per share or 17.59%
No, the average daily trading liquidity for Genomma Lab Internacional is $294 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Genomma Lab Internacional has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.28, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 1.44%, which is challenging.
We have calculated the inflation risk for Genomma Lab Internacional to be low [0.5 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.